Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo.
Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control.
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals.
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Study protocol for monitoring SARS-CoV-2 infection and its determinants in Catalonia (Spain): an observational and participatory research approach in a Sentinel Network of Schools.
Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1.
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis.